FDA Inspection 1207686 — Aizant Drug Research Solutions Private Ltd.

Aizant Drug Research Solutions Private Ltd. — FEI 3008243902

The FDA completed an inspection of Aizant Drug Research Solutions Private Ltd. on April 28, 2023 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 28, 2023
Fiscal Year
2023
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Hyderabad (India)